冠心病慢性心力衰竭患者室性心律失常临床治疗

目的：讨论在临床中对冠心病慢性心力衰竭患者存在的室性心律失常进行治疗的临床效果。方法选取我院2012年1月-2014年6月收治治疗的冠心病心力衰竭患者100例，随机的把其分成观察组与对照组，其中观察组患者通过胺碘酮进行治疗，而对照组患者选择常规治疗手段进行治疗，对两组患者的临床治疗效果进行对比分析。结果两组患者经过治疗后，对照组患者的治疗总有效率为76.0％，显效率为48.0％；而观察组患者的治疗总有效率为94.0％，显效率为80.0％；两组患者进行对比，观察组患者的临床疗效明显的高于对照组。100例冠心病衰竭患者中，出现室性心律失常的患者为46例，随着左心室内径的逐渐增大，其出现室性心律失常的概率则越高。结论对于冠心病心力衰竭来说，出现室性心律失常的概率较高，应用胺碘酮对其进行治疗，具备着非常显著的效果，在临床中值得推广与应用。

Clinical treatment of ventricular arrhythmia in coronary heart disease patients with chronic heart failure

Objective To investigate the clinical effect of treatment for ventricular arrhythmia in coronary heart disease （CHD） patients with chronic heart failure （CHF）. Methods A total of 100 cases of CHD who had CHF and were treated in our hospital between January 2012 and June 2014 were selected and randomly divided into observation group and control group. The observation group was treated with amiodarone, while the control group was treated with conventional methods. The treatment outcomes of the two groups were then compared and analyzed. Results After treatment, the overall response rate and marked response rate for the control group were 76.0% and 48.0%, respectively, versus 94.0% and 80.0% for the observation group. The comparison results showed that the patients in the observation group had significantly better clinical outcomes than those in the control group. Of the 100 CHD patients with CHF, 46 developed ventricular arrhythmia. The risk of developing ventricular arrhythmia rose with increasing left ventricular internal diameter.Conclusion Amiodarone is effective in CHD patients with CHF who are prone to ventricular arrhythmia. Thus, it deserves wide application in clinical practice.